Molecular Templates

About:

Molecular Templates is a clinical-stage biopharmaceutical company developing therapeutic compounds for cancer and other serious diseases.

Website: https://www.mtem.com/

Twitter/X: moltemp

Top Investors: Takeda, Perceptive Advisors, National Institutes of Health, Biotechnology Value Fund, Frazier Healthcare Partners

Description:

Molecular Templates is a clinical-stage biopharmaceutical company developing therapeutic compounds for cancer and other serious diseases. It primarily develops a pipeline of therapies through its proprietary biologic-engineered toxin body (ETB) drug platform with unique mechanisms of action which are highly differentiated from antibody-drug conjugates (ADCs).

Total Funding Amount:

$398M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)mtem.com

Founders:

Leigh Revers

Number of Employees:

101-250

Last Funding Date:

2024-03-28

IPO Status:

Public

© 2025 bioDAO.ai